Sangamo is pioneering the future of genomic medicine
Sangamo Therapeutics is a genomic medicine company dedicated to translating groundbreaking science into medicines that transform the lives of patients and families afflicted with serious neurological disease. Sangamo uses its deep scientific expertise and proprietary zinc finger technology to create genomic cures for patients suffering from diseases for which today’s medicine can only offer symptom management at best.
Stock Quote
Change
Volume
52 Week High
52 Week Low
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Upcoming Events
Past Events
Past Events